Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Oct 31;136(5):1043–1053. doi: 10.1084/jem.136.5.1043

STUDIES IN PORPHYRIA

I. A DEFECT IN THE REDUCTIVE TRANSFORMATION OF NATURAL STEROID HORMONES IN THE HEREDITARY LIVER DISEASE, ACUTE INTERMITTENT PORPHYRIA

Attallah Kappas 1, H Leon Bradlow 1, Peter N Gillette 1, T F Gallagher 1
PMCID: PMC2139305  PMID: 4263649

Abstract

A variety of 5β steroid metabolites derived from hormones natural to man are potent inducers experimentally of δ-aminolevulinate synthetase, the rate-limiting enzyme in porphyrin-heme formation. This mitochondrial enzyme is found at high levels of activity in the livers of patients with the genetic disease, acute intermittent porphyria (AIP). In this study the metabolism of 14C-labeled testosterone was examined in AIP patients to determine whether there was a disproportionate conversion of the hormone to its 5β, compared to its 5α metabolite. The results indicate that AIP subjects do generate a substantially greater than normal fraction of 5β metabolite from this steroid; the excessive degree of ring A reduction of testosterone taking place via the 5β pathway in the porphyric patients averages 350% greater than in the nonporphyric subjects. In one asymptomatic AIP patient the disproportionate generation of 5β metabolite from the hormone reached a level 10 times the normal mean. Studies with a second 14C-labeled hormone, dehydroisoandrosterone, whose metabolism in man resembles that of testosterone, confirmed the derangement in reductive transformation of steroids found in the individuals carrying the genetic lesion of AIP. These findings define a new endocrine abnormality in AIP patients and raise the possibility that endogenously derived 5β steroids may contribute by an induction mechanism to the increased levels of hepatic δ-aminolevulinate synthetase activity found in AIP patients.

Full Text

The Full Text of this article is available as a PDF (603.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FUKUSHIMA D. K., GALLAGHER T. F., GREENBERG W., PEARSON O. H. Studies with an adrenal inhibitor in adrenal carcinoma. J Clin Endocrinol Metab. 1960 Sep;20:1234–1245. doi: 10.1210/jcem-20-9-1234. [DOI] [PubMed] [Google Scholar]
  2. Fukushima D. K., Bradlow H. L., Yamauchi T., Zumoff B., Hellman L., Gallagher T. F. Studies with androsterone-3-3H,4-14C. J Clin Endocrinol Metab. 1967 Aug;27(8):1208–1213. doi: 10.1210/jcem-27-8-1208. [DOI] [PubMed] [Google Scholar]
  3. GALLAGHER T. F. Studies of steroid metabolism in man. Acta Endocrinol Suppl (Copenh) 1960;NaN(Suppl 50):93–97. doi: 10.1530/acta.0.xxxivs093. [DOI] [PubMed] [Google Scholar]
  4. GRANICK S., LEVERE R. D. HEME SYNTHESIS IN ERYTHROID CELLS. Prog Hematol. 1964;4:1–47. [PubMed] [Google Scholar]
  5. GRANICK S., URATA G. Increase in activity of alpha-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biol Chem. 1963 Feb;238:821–827. [PubMed] [Google Scholar]
  6. Goldberg A., Moore M. R., Beattie A. D., Hall P. E., McCallum J., Grant J. K. Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria. Lancet. 1969 Jan 18;1(7586):115–118. doi: 10.1016/s0140-6736(69)91134-9. [DOI] [PubMed] [Google Scholar]
  7. Granick S., Kappas A. Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation. J Biol Chem. 1967 Oct 25;242(20):4587–4593. [PubMed] [Google Scholar]
  8. Granick S. The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem. 1966 Mar 25;241(6):1359–1375. [PubMed] [Google Scholar]
  9. Heilmeyer L., Clotten R. Zur biochemischen Pathogenese der Pophyria acuta intermittens. Klin Wochenschr. 1969 Jan 15;47(2):71–74. doi: 10.1007/BF01745768. [DOI] [PubMed] [Google Scholar]
  10. Kappas A. Biologic actions of some natural steroids on the liver. N Engl J Med. 1968 Feb 15;278(7):378–384. doi: 10.1056/NEJM196802152780707. [DOI] [PubMed] [Google Scholar]
  11. Kappas A., Granick S. Experimental hepatic porphyria: studies with steroids of physiological origin in man. Ann N Y Acad Sci. 1968 Jul 31;151(2):842–849. doi: 10.1111/j.1749-6632.1968.tb48268.x. [DOI] [PubMed] [Google Scholar]
  12. Kappas A., Granick S. Steroid induction of porphyrin synthesis in liver cell culture. II. The effects of heme, uridine diphosphate glucuronic acid, and inhibitors of nucleic acid and protein synthesis on the induction process. J Biol Chem. 1968 Jan 25;243(2):346–351. [PubMed] [Google Scholar]
  13. Kappas A., Song C. S., Levere R. D., Sachson R. A., Granick S. THE INDUCTION OF delta-AMINOLEVULINIC ACID SYNTHETASE in vivo IN CHICK EMBRYO LIVER BY NATURAL STEROIDS. Proc Natl Acad Sci U S A. 1968 Oct;61(2):509–513. doi: 10.1073/pnas.61.2.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lees R. S., Song C. S., Levere R. D., Kappas A. Hyperbeta-lipoproteinemia in acute intermittent porphyria; preliminary report. N Engl J Med. 1970 Feb 19;282(8):432–433. doi: 10.1056/NEJM197002192820807. [DOI] [PubMed] [Google Scholar]
  15. Levere R. D., Kappas A. Biochemical and clinical aspects of the porphyrias. Adv Clin Chem. 1968;11:133–174. doi: 10.1016/s0065-2423(08)60058-x. [DOI] [PubMed] [Google Scholar]
  16. Levin J., Friedrich E. H., Lobotsky J. Steroid adsorption with polyethylene tubinh.g. J Clin Endocrinol Metab. 1965 Nov;25(11):1519–1520. doi: 10.1210/jcem-25-11-1519. [DOI] [PubMed] [Google Scholar]
  17. Marver H. S., Collins A., Tschudy D. P., Rechcigl M., Jr Delta-aminolevulinic acid synthetase. II. Induction in rat liver. J Biol Chem. 1966 Oct 10;241(19):4323–4329. [PubMed] [Google Scholar]
  18. Miyagi K., Cardinal R., Bossenmaier I., Watson C. J. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med. 1971 Nov;78(5):683–695. [PubMed] [Google Scholar]
  19. Nakao K., Wada O., Kitamura T., Uono K., Urata G. Activity of amino-laevulinic acid synthetase in normal and porphyric human livers. Nature. 1966 May 21;210(5038):838–839. doi: 10.1038/210838b0. [DOI] [PubMed] [Google Scholar]
  20. Stein J. A., Tschudy D. P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970 Jan;49(1):1–16. [PubMed] [Google Scholar]
  21. Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1315–1320. doi: 10.1073/pnas.67.3.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TSCHUDY D. P., PERLROTH M. G., MARVER H. S., COLLINS A., HUNTER G., Jr, RECHCIGL M., Jr ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME. Proc Natl Acad Sci U S A. 1965 Apr;53:841–847. doi: 10.1073/pnas.53.4.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WATSON C. J. Porphyria. Adv Intern Med. 1954;6:235–299. [PubMed] [Google Scholar]
  24. WATSON C. J., RUNGE W., TADDEINI L., BOSSENMAIER I., CARDINAL R. A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA. Proc Natl Acad Sci U S A. 1964 Aug;52:478–485. doi: 10.1073/pnas.52.2.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zimmerman T. S., McMillin J. M., Watson C. J. Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med. 1966 Sep;118(3):229–240. [PubMed] [Google Scholar]
  26. Zumoff B., Bradlow H. L., Gallagher T. F., Hellman L. Decreased conversion of androgens to normal 17-ketosteroid metabolites: a nonspecific consequence of illness. J Clin Endocrinol Metab. 1971 Jun;32(6):824–832. doi: 10.1210/jcem-32-6-824. [DOI] [PubMed] [Google Scholar]
  27. de Matteis F. Disturbances of liver porphyrin metabolism caused by drugs. Pharmacol Rev. 1967 Dec;19(4):523–557. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES